heptapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-08. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Calculated for the acetylated heptapeptide |
| Molecular weight | ~889 Da | Monoisotopic mass approximately 889.0 Da |
| Amino acid sequence | Ac-LKKTETQ | N-terminal acetylated seven-residue peptide |
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid |
| Solubility class | Water-soluble | Peptides of this size generally dissolve in aqueous media |
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
25 Jan&1 Sep) mimicking neurons' communication, is reported. 9 November IBM unveils its 433-qubit 'Osprey' quantum processor, the successor to its Eagle system. A study shows that 50+ aged users of the dietary program SNAP "had about 2 fewer years of cognitive aging over a 10-year period compared with non-users" despite it having nearly no conditions for the sustainability and healthiness of the food products purchased with the coupons (or coupon-credits). 10 November A study describes how one may eventually be able to detect (distinguish) wormholes, suggesting they may have never been observed because they appear very similar to black holes. Notable software developments: After domain seizures of Z-Library by copyright law enforcement and moves toward dark web and IPFS technologies by its content providers, the open source shadow library UI Anna's Archive – which also provides access to a full copy of Z-Library content and scientific articles – is established by a team of archivists, essentially providing the largest human book and literature library. News outlets report about the development of a post-editing model using GPT-3 that improves machine translations after identification of current translation problems (8 Nov/25 Oct). The largest global inventory and interactive map of greenhouse gas emission sources is released by Climate TRACE (9 Nov).
== Kinetics == The kinetics and rates of step-growth polymerization can be described using a polyesterification mechanism. The simple esterification is an acid-catalyzed process in which protonation of the acid is followed by interaction with the alcohol to produce an ester and water. However, there are a few assumptions needed with this kinetic model. The first assumption is water (or any other condensation product) is efficiently removed. Secondly, the functional group reactivities are independent of chain length. Finally, it is assumed that each step only involves one alcohol and one acid.
25 November Two Britons are among 17 people reported missing after a tourist boat sank in the Red Sea. Following the impact of Storm Bert, further rain is forecast over the coming two days for northern England and Wales. In an attempt to reassure industry there will not be further tax rises for business, Chancellor Rachel Reeves tells the CBI conference she is "not coming back with more borrowing or more taxes". It is reported that the UK Supreme Court is to decide on the definition of a woman following a case brought by campaigners in Scotland. 26 November Vauxhall owner Stellantis announces the closure of its van making facility in Luton, with the loss of 1,100 jobs. Starmer announces an overhaul of the UK jobs market that will see young people guaranteed places on apprenticeships or in training. A yellow weather warning is issued for flooding ahead of the arrival of Storm Conall, which is expected to affect southern England and Wales. The UK government says it has no plans for an extra bank holiday in 2025 to mark the 80th anniversary of VE Day. The City of London Corporation announces that two of Britain's most famous and historic markets – Smithfield and Billingsgate – will close after 850 years of operation. 28 November Former British army soldier Daniel Khalife is found guilty of spying for Iran. Justice Bobbie Cheema-Grubb at Woolwich Crown Court says that Khalife will face "a long custodial sentence" when he is sentenced in early 2025. Official figures indicate that net migration reached 906,000 in the year to June 2024, much higher than previously stated.
==== Anabolic and androgenic activity ==== Nandrolone has a very high ratio of anabolic to androgenic activity. In fact, many nandrolone-like anabolic steroids and even nandrolone itself are said to have among the highest ratio of anabolic to androgenic effects of all anabolic steroids. This is attributed to the fact that whereas testosterone is potentiated via conversion into dihydrotestosterone (DHT) in androgenic tissues, the opposite is true with nandrolone and similar anabolic steroids (i.e., other 19-nortestosterone derivatives). As such, nandrolone-like anabolic steroids, namely nandrolone esters, are the most frequently used anabolic steroids in clinical settings in which anabolic effects are desired; for instance, in the treatment of AIDS-associated cachexia, severe burns, and chronic obstructive pulmonary disease. However, anabolic steroids with a very high ratio of anabolic to androgenic action like nandrolone still have significant androgenic effects and can produce symptoms of masculinization like hirsutism and voice deepening in women and children with extended use.
Sources: en.wikipedia.org
== Treatment == Currently, there are no treatments for any of the congenital myopathies. Depending on the severity, there are different therapies available to help alleviate any pain and aid patients in performing varying activities. For example, many congenital myopathy patients are involved in physical or occupational therapy in an attempt to strengthen their skeletal muscles. Orthopedic surgery is usually necessary to correct skeletal deformities secondary to muscle weakness, such as scoliosis. Survival is typically determined by the level of respiratory muscle insufficiency.
==== 2400–2499 ==== County Council of Clwyd (River Dee Estuary Bridge) Scheme 1992 Confirmation Instrument 1993 (S.I. 1993/2400) Environmental Protection (Prescribed Processes and Substances) (Amendment) (No. 2) Regulations 1993 (S.I. 1993/2405) Offshore Safety Act 1992 (Commencement No. 1) Order 1993 (S.I. 1993/2406) Leasehold Reform (Collective Enfranchisement and Lease Renewal) Regulations 1993 (S.I. 1993/2407) Rent Assessment Committee (England and Wales) (Leasehold Valuation Tribunal) Regulations 1993 (S.I. 1993/2408) Leasehold Reform (Notices) (Amendment) Regulations 1993 (S.I. 1993/2409) Local Government and Housing Act 1989 (Commencement No. 16) Order 1993 (S.I. 1993/2410) National Health Service (General Medical Services) Amendment (No. 2) Regulations 1993 (S.I. 1993/2421) Environmentally Sensitive Areas (Ynys Mo*n) Designation (Amendment) Order 1993 (S.I. 1993/2422) Patents (Amendment) Rules 1993 (S.I. 1993/2423) Pembrokeshire National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2436) Strathclyde Region (Electoral Arrangements) Order 1993 (S.I. 1993/2439) Finance Act 1993, Section 18, (Appointed Day) Order 1993 (S.I. 1993/2446) National Health Service (General Medical and Pharmaceutical Services) (Scotland) Amendment (No. 2) Regulations 1993 (S.I. 1993/2449) Social Fund Cold Weather Payments (General) Amendment Regulations 1993 (S.I. 1993/2450) National Health Service (Pharmaceutical Services) Amendment Regulations 1993 (S.I. 1993/2451) Vehicles Excise Duty (Simplification of Goods Vehicles Rates) Order 1993 (S.I.
The exact dose of lithium given varies depending on factors such as the patient's serum lithium concentrations, which must be closely monitored by a physician to avoid lithium toxicity and potential kidney damage (or even kidney failure) from lithium-induced nephrogenic diabetes insipidus. Dehydration and certain drugs, including NSAIDs such as ibuprofen, can increase serum lithium concentrations to unsafe levels whereas other drugs, such as caffeine, may decrease concentrations.
Nα-acetylpeptide + CoA Thus, the two substrates of this enzyme are acetyl-CoA and peptide, whereas its two products are Nα-acetylpeptide and CoA. Since 2016, the different enzymes that used to be in this class are separated into NatA-NatF (EC 2.3.1.254 to EC 2.3.1.259). These enzymes belong to the family of transferases, specifically those acyltransferases transferring groups other than aminoacyl groups. The systematic name of this enzyme class is acetyl-CoA:peptide Nα-acetyltransferase. Other names in common use include beta-endorphin acetyltransferase, peptide acetyltransferase, protein N-terminal acetyltransferase, NAT, Nalpha-acetyltransferase, amino-terminal amino acid-acetylating enzyme, and acetyl-CoA:peptide alpha-N-acetyltransferase.
The ambitious hydro-electric project was intended to carry electricity across the South China Sea to satisfy electricity demand in peninsular Malaysia. Work on the dam was eventually suspended due to the Asian financial crisis. In 1995, Mahathir visited the Massachusetts Institute of Technology (MIT) and facilitated the establishment of a university modelled after MIT, leading to the founding of the Malaysia University of Science & Technology (MUST). The 1997 Southeast Asian haze, the worst haze event in history caused by Indonesian forest fires, was a major air pollution crisis for the country; Mahathir launched a cross-border firefighting operation in response.
Sources: en.wikipedia.org
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.
No. Thymosin beta-4 is a 43-amino-acid protein, while TB-500 represents only a short N-terminal segment. The two should not be treated as interchangeable in experimental design.
It is often called a thymosin beta-4 fragment, Tβ4 fragment, or Ac-LKKTETQ. The name TB-500 is mainly a commercial or catalog label rather than a formal chemical name.
TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.